AI assistant
CME GROUP INC. — Director's Dealing 2025
May 7, 2025
29871_dirs_2025-05-07_50d9a73e-63d2-476e-bab9-ec1acb544685.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2025-03-15
Reporting Person: Sammann Derek (Sr MD Gl Hd Commodities Mkts)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-15 | Common Stock Class A | A | 3883 | $258.68 | Acquired | 13300 | Direct |
| 2025-03-15 | Common Stock Class A | F | 1708 | $258.68 | Disposed | 11592 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock Class A | 10811 | Indirect |
| Common Stock Class A | 14614 | Indirect |
Footnotes
F1: For the PSAs granted in September 2021: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024.
F2: The original Form 4 filed on March 18, 2025 is being amended to update the number of shares held directly and indirectly after a late form 5 was filed on May 5, 2025 to reflect the transfer of CME Group Class A common stock on October 31, 2024 to reporting person's revocable living trust. This Form 4/A is being filed to update the number of securities held directly and indirectly following this transaction.
F3: Mr. Sammann surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.